February 2024 - Page 3 of 3 - BioMedWire (BMW)

MondayFeb 05, 2024 12:00 pm

Astiva Health Differentiating Itself in Medicare Market, Working to Provide ‘Robust, Stable’ Offerings

CMS forecasts enrollment in Medicare Advantage programs will increase from 31.6 million in 2023 to 33.8 million in 2024 Astiva Health recently expanded into three Southern California counties, resulting in the company reaching the 10,000-member milestone mark Astiva is committed to reshape healthcare delivery, increased access to quality healthcare In a space where a growing number of individuals are qualifying for Medicare, Astiva Health is differentiating itself as a fast-growing Medicare Advantage Prescription Drug (“MAPD”) health plan focused on redefining the standards of personalized and comprehensive healthcare. As an indication of its success in, Astiva company recently reached a key milestone, surpassing the…

MondayFeb 05, 2024 10:45 am

Scientists Start Trialing First Blood Test Against Brain Cancer

Brain tumors, which affects thousands of individuals around the globe, can be diagnosed using various imaging techniques, including magnetic resonance imaging (MRI) and computed tomography (CT) scans. Some tumors cannot be diagnosed using these techniques, however, which makes it hard for them to be detected earlier. In the United Kingdom, brain tumors kill more individuals aged 40 and below than any other cancer. Now, researchers have developed a blood test that may revolutionize the diagnosis of brain cancer. The blood test, called the TriNetra-Glio test, may help diagnose patients with different types of brain cancer earlier, which could eliminate the…

MondayFeb 05, 2024 9:00 am

Astrotech Corp. (NASDAQ: ASTC) Positioning TRACER 1000(TM) as Next-Generation Solution for the Explosive Trace Detector Market

1st Detect, a wholly owned subsidiary of mass spectrometry company Astrotech, is offering its breakthrough TRACER 1000(TM) Explosive Trace Detector (“ETD”) in markets that accept ECAC certification The TRACER 1000(TM) ETD is designed to outperform ETDs currently used at airports, cargo and other secured facilities, as well as at borders Astrotech is working to position its product as the next-generation solution for the ETD market at a time when many of the existing IMS-based ETDs are due for replacement Keenly watching the developments in the field of explosives and narcotics detection at airports is Astrotech (NASDAQ: ASTC), a mass spectrometry…

FridayFeb 02, 2024 12:48 pm

New Study Challenges Perception of Males Being More Susceptible to Autism

A research team led by Manish Kumar Tripathi, a neuroscientist from the Hebrew University of Jerusalem, has published findings challenging the idea that males are more susceptible to autism than females. The team studied the condition in a mouse model and found that both male and female brains have equal chances of developing the condition. Autism is a neurological and developmental disorder that affects how individuals learn, communicate, behave and interact with others. While autism is diagnosable at nearly any age, it is typically classified as a “developmental disorder” because its symptoms usually appear in the first two years of…

ThursdayFeb 01, 2024 2:12 pm

Why Prescription Drugs Can Be Costly

Prescription drugs have had a significant impact on human society. From treating temporary conditions and controlling chronic conditions, prescription drugs have been critical to preserving long-term health and quality of life for millions of people for well over a century. However, prescription drugs tend to be quite expensive in the United States when compared to other countries. A 2023 RAND Corporation study found that brand-name prescription drug prices in the U.S. were 3.44 times higher compared to 32 similar nations. According to a Kaiser Family Foundation Health Tracking Poll, 8 in 10 U.S. adults believe prescription medication prices in the…

ThursdayFeb 01, 2024 9:00 am

Astiva Health CEO Dr. Tri Nguyen Discusses Company’s Growth and Vision on The Bell2Bell Podcast

In a recent episode of the 'Bell2Bell Podcast' hosted by Stuart Smith, Astiva Health was spotlighted as a significant player in the Medicare Advantage Prescription Drug (“MAPD”) sector. The episode featured an exclusive interview with Astiva Health’s Co-Founder and CEO, Dr. Tri Nguyen, a renowned expert in internal medicine and cardiology. Listen to the full interview to hear Dr. Nguyen discuss Astiva Health’s journey since its inception in 2020 and its expansion plans. He shared insightful details about the company's expansion to Los Angeles, San Bernardino, and Riverside from January 1, 2024, marking a pivotal phase in transforming healthcare delivery.…